Thursday, 17 August 2017

Australia News

  • GSK to shut down its Sydney plant by 2020

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2016

    Singapore: According to reports, British drug giant GlaxoSmithKline will close its Sydney plant by 2020 after a review determined it was not competitive long term. The move will impact near...Read more

  • Australia changes drug approval norms to speed up approval process

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2016

    Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal government is implementing new measures for approval of new medicine...Read more

  • Hypoglycaemia monitor for diabetics wins award

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2012

    AIMEDICS, an Australian medical device company, has come up with a device that help people with insulin-dependent diabetes mellitus (IDDM) by detecting and preventing sleep-time hypoglycem...Read more

  • Research and innovation critical for productivity'

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 16 Jun, 2014

    Singapore: The report, entitled 'The role of science research and technology in lifting Australian productivity,' makes 25 key findings about Australia's current performance and outlines op...Read more

  • Phosphagenics patch delivers Oxymorphone for 72 hours

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013

    Singapore: Australian drug delivery technology company, Phosphagenics highlighted that it has achieved all end points of its important phase I trial of its oxymorphone patch by successfully...Read more

  • New Australian facility to translate research into products

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2012

    Singapore: Australian life sciences researchers will now be able to translate their discoveries into commercial products faster with the newly established Queensland Node of the Therapeutic...Read more

  • Specialized Therapeutics grants sublicense to Mundipharma for anti-emetic products

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2016

    Singapore: Specialized Therapeutics Pty Ltd and Mundipharma Pty Limited announce a sublicense agreement enabling Mundipharma to assume all commercialization responsibilities for the anti-em...Read more

  • CardioCel heals the heart by attracting stem cells

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 28 Nov, 2012

    Singapore: Australia-based Allied Healthcare has demonstrated that its cardiovascular patches, CardioCel, promote healing at the site of repair of heart valves. The study was undertaken in...Read more

  • Novogen progresses on drugs against genetic, degenerative disorders

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013

    Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a wide range of genetic and non-genetic degenerative diseases, has met ...Read more

  • It's all in the genes!

    Australia |  News | By Aishwarya Venkatesh | 0 Comment | 19 Aug, 2016

    Singapore: WHO estimates that globally, nearly 350 million people suffer from depression. As explained by the health governing bodies, depression is a common illness worldwide and is differ...Read more

  • Lab-to-market is a challenge for Aussie researchers

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 12 Oct, 2012

    Australia: Mr David Henderson, MD of UniQuest, which is one of the technology transfer companies in the Asia Pacific region, believes that tech transfer organizations act as the pivotal poi...Read more

  • Vaxxas' painless vaccine delivery tech fetches BioSpectrum award

    Australia |  Influencers | By Amrita Tejasvi | 0 Comment | 15 Mar, 2013

    Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland, came up with the idea of nanopatch technology in 2003. The te...Read more

  • Bone Medical reveals results of arthritis study

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013

    Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for musculoskeletal diseases, revealed its initial findings from a proof-of-...Read more

  • Stem cell study reveals potential diabetes cure

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012

    Singapore: A research conducted by Australian scientists on stem cells has shown that patients suffering from type 1 diabetes have the ability to make their own insulin thus erasing the nee...Read more

  • Aussie firm grows human tendons in lab

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 10 Nov, 2014

    Australia: Australia based regenerative medicine company, Orthocell, has successfully grown human tendons in a laboratory. The research was conducted in collaboration between Orthocell, Un...Read more

  • Australia announces victory over AIDS

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 14 Jul, 2016

    Singapore: Ahead of the 21st International AIDS Conference, a team of Australian researchers and experts from the Australian Federation of Aids Organisations have made an announcement stati...Read more

  • There's still time to stop TPP from cutting off critical affordable generic medicines: MSF

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2016

    Singapore: As representatives from the United States and 11 other Pacific-Rim countries gather in New Zealand to sign the Trans-Pacific Partnership (TPP) trade agreement today, the fight to...Read more

  • Luye Medical integrates Australia's Healthe Care to its group

    Australia |  News | By BioSpectrum Bureau | 0 Comment | 05 May, 2016

    Healthe Care, Australia's third largest private healthcare group, officially became a member of Singapore-headquartered, Luye Medical Group Pte Ltd after the AU $938 million acquisition fro...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls